Hospital Shares

Systematix bets on Rainbow Medicare's pan-India leap; sees 27% upside

Rainbow Children's Medicare, India's only listed pediatric and maternity care chain, operates 22 hospitals and 5 clinics with around 2,235 beds across nine cities.

Medanta, Max: Analysts pick best hospital stocks to buy post CGHS revision

The CGHS rate revision could lift hospital chains' revenues and margins, say analysts. Here are the listed stocks set to benefit most from the policy update

Hospital stocks in demand; Narayana, HCG hit new high, Yatharth surges 6%

Shares of Hospital firms gained amid rising demand for specialized treatments, including oncology and high-end surgical procedures; this trend contributes to higher ARPOB and overall revenue growth.

HMPV scare: Vijaya, Dr Lal Path, healthcare stocks in focus; Time to buy?

Apollo Hospitals, Vijaya Diagnostic and Narayana Hrudayalaya have given a fresh breakout on the daily scale. Charts show that these 5 healthcare related shares can rally up to 11 per cent.

Nephro Care IPO: Anchor investors, share allotment, issue objective

Nephro Care India IPO: This NSE-SME IPO was subscribed 5.5 times within hours on Day 1 of the offer period.

GQG Partners sells hospital chain Max Healthcare shares through open market

Last year, GQG Partners had acquired shares of hospital chain Max Healthcare Institute in a bulk deal for Rs 415 crore through an open market transaction

Max Healthcare to acquire Nagpur-based Alexis Hospital for Rs 412 rore

Max Healthcare added that the bed capacity can be expanded to 340 beds in view of the availability of the floor area ratio for the given land and the strength of the existing structure

Max Healthcare acquires Nagpur-based Alexis Hospital for Rs 412 cr

Acquisition strengthens presence in Maharashtra and part of strategy to expand in Tier-II cities, says Max Healthcare

Hospitals get post-Covid growth injection from foreign medical tourism

Robust growth in H1FY24 signals rebound in medical tourism, fuels bigger expectations

As costly bills hurt patients, rising ARPOB helps improve hospital earnings

ARPOB refers to the average revenue per operating bed which has gone up from Rs 37,397 in FY20 to Rs 57,760 for the first quarter of the ongoing financial year

Yatharth Hospital extends rally, surges 29% in a week on strong Q1 results

In Q1FY24, average revenue per operating bed (ARPOB) increased to Rs 28,140, compared to Rs 27,706 in Q4FY23 and Rs 26,457 in Q1FY23.

Yatharth Hospital debuts on a quiet note, commands 14% gain at day's high

The stock moved higher to Rs 341, a 14% premium against its issue price of Rs 300 per share, after listing at Rs 306.10 on the NSE.

AIIMS Delhi server down, government suspects ransomware attack

A ransomware attack on the AIIMS Delhi server halted day-to-day activities including OPD registrations and blood sample reports at the hospital today

How did IHH Healthcare manage to nurse Fortis hospitals back to health

After a bruising bidding war four years ago, Fortis has moved to pare its debt and expand modestly

Analysts bullish on hospitals on expansion plans, recovery in non-Covid biz

Experts note that the transition of the sector to the asset-light model has significantly enabled it to use fewer funds for setting up hospitals, thus bringing significantly higher returns on equity

Yatharth Hospital & Trauma Care Services files initial papers for IPO

Yatharth Hospital & Trauma Care Services Ltd has filed preliminary papers with Sebi for an initial public offering that will include sale of fresh equity shares worth Rs 610 crore. The company operates and manages private hospitals in the Delhi-NCR region. The Initial Public Offering (IPO) consists of a fresh issue of equity shares aggregating up to Rs 610 crore and an Offer For Sale (OFS) offer for sale of up to 65.51 lakh equity shares by the company's promoters and promoter group entities. As many as 37.43 lakh equity shares would be sold by Vimla Tyagi, 20.21 lakh equity shares by Prem Narayan Tyagi and 7.87 lakh equity shares by Neena Tyagi. The company may also consider a pre-IPO placement aggregating up to Rs 122 crore. The firm intends to utilise the net proceeds for repayment or prepayment in full or part of certain borrowings availed by the company and its subsidiaries, and for funding capital expenditure expenses, among others. The proceeds will also be used for fundin

Street sees stent, drug price control clouding prospects of hospital firms

Share prices of hospital majors have seen corrections in the past 2 months